Contact
Please use this form to send email to PR contact of this press release:
Introducing Jubbonti® and Wyost®, the first denosumab biosimilars on the Canadian market
TO:
Please use this form to send email to PR contact of this press release:
Introducing Jubbonti® and Wyost®, the first denosumab biosimilars on the Canadian market
TO: